Posts By Alex
883Wire StoriesGrAI Matter Labs and ADLINK Announce Their Partnership to Integrate SMARC Module with GrAI VIP
PARIS–(BUSINESS WIRE)–GrAI Matter Labs (GML), a pioneer of brain-inspired ultra-low latency computing, and ADLINK Technology Inc., a global leader in edge computing,...
- 690Wire Stories
Myanmar Crawler Excavator Market Report 2021: Strategic Assessment & Forecasts to 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Myanmar Crawler Excavator Market – Strategic Assessment & Forecast 2021-2027” report has been added to ResearchAndMarkets.com’s offering. Myanmar crawler excavator...
- 746Wire Stories
Montréal Exchange Extends Trading Hours to Asia Pacific Time Zones
Canada’s Derivatives Exchange further expands global reach, syncing trading hours with Asia Pacific markets in support of growing investor demand MONTRÉAL–(BUSINESS WIRE)–Montréal...
- 819Wire Stories
Fusionex Signs MoU with Alliance Islamic Bank to Accelerate SMEs’ Halal Business Growth
PETALING JAYA, Malaysia–(BUSINESS WIRE)–#AllianceIslamicBank–Artificial Intelligence and Big Data technology market leader Fusionex recently signed an MoU with Alliance Islamic Bank Berhad to...
- 1.1KWire Stories
Rio Tinto to triple Weipa solar capacity and add battery storage to help power operations
MELBOURNE, Australia–(BUSINESS WIRE)–Rio Tinto has approved a new solar farm and battery storage at Weipa in Queensland, in a move that will...
- 1.0KWire Stories
Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations
Sub-analysis of TROPION-PanTumor01 phase 1 trial of datopotamab deruxtecan featured as late-breaking Mini Oral presentation at ESMO TROPION-Lung05 phase 2 trial currently...
- 798Wire Stories
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
The approval marks the first time a monoclonal antibody treatment for COVID-19 received full approval to treat patients with COVID-19 The approval...
- 740Wire Stories
ENHERTU® Demonstrated Robust and Durable Tumor Response of 54.9% in Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer
First HER2 directed therapy to show a strong tumor response in this population Data from HER2 mutant cohort of pivotal DESTINY-Lung01 phase...
- 748Wire Stories
Enfusion Files Registration Statement with SEC for Proposed Initial Public Offering
NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (“Enfusion”), a leading provider of cloud-based investment management software and services, today announced...
- 675Wire Stories
Metals Acquisition Corp. Announces the Separate Trading of its Shares of Class A Ordinary Shares and Redeemable Warrants Commencing September 20, 2021
FORT WORTH, Texas–(BUSINESS WIRE)–Metals Acquisition Corp. (NYSE: MTAL.U) (the “Company”) announced that, commencing September 20, 2021, holders of the units sold in...
